Gene and Cell Therapy – News and Features

Statistically significant improvements in function in spinal cord injury model with ZFP TF treatment to be shown at American Society for Neural Therapy and Repair meeting.

Oxford scientists have uncovered that the gene Nephroblastoma Overexpressed plays a key role in regulating the production of blood from stem cells.

The Tulane Center has received a four-year grant of $1.75 million from the National Heart, Lung and Blood Institute to study ways that adult stem cells might repair damaged heart tissue.

The alliance aims to deliver software and services to manufacturers of personalized therapies and vaccines based on genetic markers.

The law was hailed by a University of Arkansas for Medical Sciences physician as a method for promoting potentially life-saving treatments in Arkansas.

Athersys achieves important milestones in commercial collaborations with Bristol-Myers Squibb and Angiotech.

Re-examination was initiated by Foundation for Taxpayer and Consumer Rights and Public Patent Foundation.

NeoStem has announced the latest article in a growing body of press coverage on the trend toward long-term banking of adult stem cells appeared recently in the San Diego Business Journal.

The project is entitled “Characterization of New Human Embryonic Stem Cell Lines and the Differentiation into Retinal Progenitor Cell”.

The University of Wisconsin will take part in a clinical trial that involves investigation of patient’s own stem cells to treat severe coronary artery disease.